Alexandar Tzankov

Hands-On Experience: Accreditation of Pathology Laboratories according to ISO 15189

Alexandar Tzankov, Luigi Tornillo, A. Tzankov, 2016, Pathobiology.

Intraoperative frozen section consultation by remote whole-slide imaging analysis –validation and comparison to robotic remote microscopy

Daniel Baumhoer, Alexandar Tzankov, Thomas Menter, 2019, Journal of Clinical Pathology.

Tissue microarray technology: principles, pitfalls and perspectives—lessons learned from hematological malignancies

Alexandar Tzankov, P. Went, A. Tzankov, 2005, Experimental Gerontology.

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.

Axel Haverich, Tobias Welte, Alexandar Tzankov, 2020, The New England journal of medicine.

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker

Ken H. Young, Lydia Sánchez, Alexandar Tzankov, 2016, Oncotarget.

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

Ken H. Young, Youli Zu, Govind Bhagat, 2015, Oncotarget.

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin’s lymphoma

Stefano A Pileri, Alexandar Tzankov, S. Pileri, 2008, Haematologica.

Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization

Alexandar Tzankov, Spasenija Savic, M. Fiegl, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.